124 related articles for article (PubMed ID: 38009865)
1. Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: The role of nerve excitability testing.
Chiorazzi A; Canta A; Carozzi VA; Meregalli C; Pozzi E; Ballarini E; Rodriguez-Menendez V; Marmiroli P; Cavaletti G; Alberti P
J Peripher Nerv Syst; 2024 Mar; 29(1):47-57. PubMed ID: 38009865
[TBL] [Abstract][Full Text] [Related]
2. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
[TBL] [Abstract][Full Text] [Related]
3. Nerve excitability assessment in chemotherapy-induced neurotoxicity.
Park SB; Lin CS; Kiernan MC
J Vis Exp; 2012 Apr; (62):. PubMed ID: 22565594
[TBL] [Abstract][Full Text] [Related]
4. Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity.
Meregalli C; Fumagalli G; Alberti P; Canta A; Chiorazzi A; Monza L; Pozzi E; Carozzi VA; Blennow K; Zetterberg H; Cavaletti G; Marmiroli P
Arch Toxicol; 2020 Jul; 94(7):2517-2522. PubMed ID: 32333051
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023
[TBL] [Abstract][Full Text] [Related]
6. Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?
Ballarini E; Malacrida A; Rodriguez-Menendez V; Pozzi E; Canta A; Chiorazzi A; Monza L; Semperboni S; Meregalli C; Carozzi VA; Hashemi M; Nicolini G; Scuteri A; Housley SN; Cavaletti G; Alberti P
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077454
[TBL] [Abstract][Full Text] [Related]
7. Effect of age on metabolomic changes in a model of paclitaxel-induced peripheral neurotoxicity.
Bonomo R; Canta A; Chiorazzi A; Carozzi VA; Meregalli C; Pozzi E; Alberti P; Frampas CF; Van der Veen DR; Marmiroli P; Skene DJ; Cavaletti G
J Peripher Nerv Syst; 2024 Mar; 29(1):58-71. PubMed ID: 38126610
[TBL] [Abstract][Full Text] [Related]
8. Translating morphology from bench side to bed side via neurophysiology: 8-min protocol for peripheral neuropathy research.
Monza L; Fumagalli G; Chiorazzi A; Alberti P
J Neurosci Methods; 2021 Nov; 363():109323. PubMed ID: 34391792
[TBL] [Abstract][Full Text] [Related]
9. Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity.
Canta A; Chiorazzi A; Pozzi E; Fumagalli G; Monza L; Meregalli C; Carozzi VA; Rodriguez-Menendez V; Oggioni N; Näsström J; Marmiroli P; Cavaletti G
Antioxidants (Basel); 2020 Jul; 9(7):. PubMed ID: 32645985
[TBL] [Abstract][Full Text] [Related]
10. Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity.
Meregalli C; Monza L; Chiorazzi A; Scali C; Guarnieri C; Fumagalli G; Alberti P; Pozzi E; Canta A; Ballarini E; Rodriguez-Menendez V; Oggioni N; Cavaletti G; Marmiroli P
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494384
[TBL] [Abstract][Full Text] [Related]
11. Acute changes in nerve excitability following oxaliplatin treatment in mice.
Makker PGS; White D; Lees JG; Parmar J; Goldstein D; Park SB; Howells J; Moalem-Taylor G
J Neurophysiol; 2020 Jul; 124(1):232-244. PubMed ID: 32519566
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel increases axonal localization and vesicular trafficking of Nav1.7.
Akin EJ; Alsaloum M; Higerd GP; Liu S; Zhao P; Dib-Hajj FB; Waxman SG; Dib-Hajj SD
Brain; 2021 Jul; 144(6):1727-1737. PubMed ID: 33734317
[TBL] [Abstract][Full Text] [Related]
13. Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies.
Krøigård T; Schrøder HD; Qvortrup C; Eckhoff L; Pfeiffer P; Gaist D; Sindrup SH
Eur J Neurol; 2014 Apr; 21(4):623-9. PubMed ID: 24460946
[TBL] [Abstract][Full Text] [Related]
14. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
Chine VB; Au NPB; Kumar G; Ma CHE
Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
[TBL] [Abstract][Full Text] [Related]
15. Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings.
Argyriou AA; Park SB; Islam B; Tamburin S; Velasco R; Alberti P; Bruna J; Psimaras D; Cavaletti G; Cornblath DR;
J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1361-1369. PubMed ID: 31256000
[TBL] [Abstract][Full Text] [Related]
16. Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer.
Otsuka R; Iwasa S; Yanai T; Hirano H; Shoji H; Honma Y; Okita N; Takashima A; Kato K; Hashimoto H; Sekiguchi M; Makino Y; Boku N; Yamaguchi M
Int J Clin Oncol; 2020 Apr; 25(4):595-601. PubMed ID: 31853798
[TBL] [Abstract][Full Text] [Related]
17. Early changes in tests of peripheral nerve function during oxaliplatin treatment and their correlation with chemotherapy-induced polyneuropathy symptoms and signs.
Krøigård T; Svendsen TK; Wirenfeldt M; Schrøder HD; Qvortrup C; Pfeiffer P; Gaist D; Sindrup SH
Eur J Neurol; 2020 Jan; 27(1):68-76. PubMed ID: 31373417
[TBL] [Abstract][Full Text] [Related]
18. Comparative Analysis of Chemotherapy-Induced Peripheral Neuropathy in Bioengineered Sensory Nerve Tissue Distinguishes Mechanistic Differences in Early-Stage Vincristine-, Cisplatin-, and Paclitaxel-Induced Nerve Damage.
Pollard KJ; Bolon B; Moore MJ
Toxicol Sci; 2021 Feb; 180(1):76-88. PubMed ID: 33410881
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of neurotoxicity of anticancer drugs using nematode Caenorhabditis elegans as a model organism.
Sakaguchi Y; Mizukami M; Hiroka Y; Miyasaka K; Niwa K; Arizono K; Ichikawa N
J Toxicol Sci; 2023; 48(6):311-321. PubMed ID: 37258236
[TBL] [Abstract][Full Text] [Related]
20. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
Geisler S; Doan RA; Strickland A; Huang X; Milbrandt J; DiAntonio A
Brain; 2016 Dec; 139(Pt 12):3092-3108. PubMed ID: 27797810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
